Keyphrases

1. 5-hydroxytryptamine 2A Receptor 15%
2. Allergic Diseases 15%
3. Anthropometric Measurements 16%
4. Aripiprazole 15%
5. Atopy 15%
6. Bisphosphonates 16%
7. Breast Cancer Patients 18%
8. Capecitabine 32%
9. Carboxyl 17%
10. Cerebral Palsy children 30%
11. Chronic Hepatitis C 39%
12. Clinical Research 18%
13. Clinical Trials 18%
14. Collagen 31%
15. Confidence Interval 18%
16. COVID-19 Pandemic 18%
17. Efficacy Evaluation 22%
18. Evaluation Period 22%
19. Gene Candidates 15%
20. Group Studies 30%
21. Hemoglobin 17%
22. Hepatic Fibrosis 22%
23. HER2 Status 15%
24. Human Epidermal Growth Factor Receptor 2 (HER2) 30%
25. Human Platelets 15%
26. In Situ Hybridization 15%
27. Insulin Resistance 30%
28. Invasive Breast Carcinoma 15%
29. Malnutrition 32%
30. Micronutrients 20%
31. Non-interventional 19%
32. Odds Ratio 16%
33. Oncology 30%
34. Oxaliplatin 17%
35. Pharmacological Challenge 15%
36. Phospholipase 45%
37. Phospholipase C gamma 2 18%
38. Platelet Aggregation 25%
39. Platelets 38%
40. Radiation Oncology 15%
41. Receptor Activation 20%
42. Receptor Gene 15%
43. Renal Anemia 30%
44. Rotavirus Infection 15%
45. Serum Micronutrients 15%
46. T102C 15%
47. Terminal Sequence 15%
48. Treatment Adherence 15%
49. Turkey 100%
50. Turkish Society 15%